Table of Contents
List of Tables & Figures
Global Parkinson’s disease Therapeutics Market is segmented By Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Others (includes Anticholinergic Drugs, Antihistaminics)), By Route of Administration (Oral, Transdermal, Subcutaneous, Others (Intestinal Infusion)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online sales), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029
The Global "Parkinson’s disease Therapeutics Market" is expected to grow at a high CAGR of 12.4% during the forecasting period (2022-2029).
Patient Derived Xenograft (PDX) Models Market
Krabbe Disease Treatment Market
Buy this report
Proceed to Buy